Inflammatory Bowel Diseases · 2004 · 45 citations · 38 references
MedicineImmunologyPathologyClinical ImmunologyImmunopathologyNeoplasiaGastrointestinal LymphomaGastrointestinal NeoplasmsGastrointestinal PathologyGut-associated Lymphoid TissueLymphoid NeoplasmsLymphoid TissueCrohn Disease PathologyEpstein-barr Virus - Associated Lymphoid NeoplasmsEpstein-barr Virus - Associated MalignanciesNeoplastic DiseaseThiopurine Therapy
Although no increased risk of developing lymphoproliferative disorders has been observed in population-based studies of patients with Crohn's disease, the possibility has been suggested in the subset of patients previously treated with thiopurine metabolites and suffering from concomitant Epstein-Barr virus infection. A few cases of lymphomas have occurred in patients with Crohn's disease treated with infliximab, only one of whom showed the presence of the Epstein-Barr virus genome. We here describe the case of a patient with steroid-dependent ileal Crohn's disease treated with azathioprine and a single infusion of infliximab, who developed a diffuse large B cell ileal lymphoma. Epstein-Barr virus genome was detected in the neoplastic cells by means of polymerase chain reaction. Epstein-Barr virus may be detected in the neoplastic tissues of lymphomas of patients with Crohn's disease treated with immunosuppressants and infliximab. The identification of such cases may help to define the frequency of this association and how to manage the lymphoproliferative disorder.
38
Jeffrey I. Cohen · New England Journal of Medicine · 2000 · 1.6K citations
Cancer risk in patients with inflammatory bowel disease
Çharles N. Bernstein, James Blanchard, Erich V. Kliewer et al. · Cancer · 2001 · 1.2K citations · Full text
Incidence of Cancer Among Patients With Rheumatoid Arthritis
Gloria Gridley, J. K. McLaughlin, Anders Ekbom et al. · JNCI Journal of the National Cancer Institute · 1993 · 586 citations
Medicine, Immunology, Oncology +17